The humanitarian organisation Médecins Sans Frontières (MSF) has declared the spread of Ebola in the Democratic Republic of Congo (DR Congo) ‘deeply alarming’, prompting the UK to ready an emergency medical team for deployment. This is not a new crisis but the deepening of an old one: the war against a virus that exploits broken health systems and porous borders.
As of the latest MSF situation report, confirmed cases have surged beyond previous containment zones, with clusters now appearing in urban centres where population density increases transmission risk. The virus, which causes haemorrhagic fever with a fatality rate of up to 90% in untreated cases, is spreading faster than the response can contain. The UK’s emergency medical team, composed of specialists in infectious disease control and isolation protocols, is on standby for deployment within 48 hours.
This outbreak is occurring against a backdrop of ongoing conflict in eastern DR Congo, which has displaced thousands into overcrowded camps where clean water and medical care are scarce. The convergence of violence and disease creates a perfect storm. Ebola is transmitted through direct contact with bodily fluids, meaning that understaffed clinics and unsafe burial practices amplify its reach. Each new case represents a failure of surveillance and a delay in contact tracing.
The scientific reality is stark: the strain circulating is the Zaire ebolavirus, for which an effective vaccine (rVSV-ZEBOV) exists. Yet vaccine distribution is hampered by cold chain requirements and logistical challenges in a region where roads are often impassable during the rainy season. MSF reports that vaccination teams have been blocked from entering some areas due to security concerns. The virus does not respect borders; it will continue to spread until herd immunity is achieved or transmission is broken through rigorous public health measures.
The UK’s readiness to deploy is a reflection of the global interconnectivity of infectious disease threats. International health regulations require countries to prepare for such eventualities, but preparedness is not enough. The response must be adequate. The World Health Organization (WHO) has classified the risk as high at the national and regional levels, yet funding shortfalls persist. Last year’s Ebola outbreak in Uganda was contained largely due to swift international support. That same urgency is required now.
For the people of DR Congo, this is not an abstract threat. They have experienced repeated Ebola outbreaks, and the trauma of survival is compounded by the knowledge that each outbreak could have been prevented with stronger health systems. The UK medics preparing for deployment will work alongside local healthcare workers who face infection risk daily. They will set up treatment centres, train staff in infection control, and coordinate with community leaders to reduce stigma around seeking medical care.
The ‘calm urgency’ of this situation cannot be overstated. We have the tools to stop Ebola: vaccines, antivirals (such as remdesivir and monoclonal antibodies), and evidence-based control measures. What we lack is the political will and sustained investment to apply them effectively. This is not a scientific problem but an implementation problem. The spread of Ebola in DR Congo is a symptom of a failing global health security architecture, one that prioritises reaction over prevention.
As the UK prepares its deployment, the question is not whether the outbreak can be contained but whether it will be contained before it crosses borders. The answer lies in the speed and scale of the international response. The world is watching, and the virus is waiting.
